Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Cardiovascular diseases 13

Cardiovascular Diseases

MedTech News for Asahi, Prosoma, and Zynex

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Asahi Intecc Partners with Penumbra; Prosoma and EVERSANA Announce Commercialisation Partnership; Zynex Starts Enrollment in the Blood Loss Detection Clinical Trial; Reva Initiates Enrollment in the MOTIV IDE Clinical Trial; FDA Clearance to QT Imaging to Calculate Fibroglandular Volume of the Breast; FDA 510k Clearance to iMediSync’s EEG scanner ‘iSyncWave’

Asahi Intecc partners with Penumbra to roll out Indigo System in Japan On September 22, 2022, Asahi Intecc, a Surgical and medical instrument manufacturing company, partnered with Penumbra, a medical device company headquartered in Alameda, California, to roll out Indigo System in Japan. After getting regulatory permission, US-based Penumbra partnered with Japanese medical device maker Asahi Intecc to introduce its Indigo Aspiration System in Japan. With the use of the minimally invasive Indigo Aspiration System, blood flow can be restored as emboli and thrombi are removed from vessels in the peripheral arterial and venous systems and treated for pulmonary embol...

Explore More...

Amyotrophic Lateral Sclerosis Pipeline

Top 10 Most Promising Drugs In The Amyotrophic Lateral Sclerosis Treatment Landscape

Digital Therapeutics

Treating Patients with Software: Digital Therapeutics

wearable-technology-devices-in-the-healthcare-wellness-and-fitness-industry

Will Wearable Devices be Streamlined in Healthcare?

Creating Future of MedTech Industry with Artificial Intelligence

Creating Future of MedTech Industry with Artificial Intelligence

Different-Types-of-Alternative-Medicine

The State of Alternative Medicine In The Healthcare

Healthcare-Delivery-System

Healthcare Delivery System: What lies in the future?

Default Blog Image

Boehringer Ingelheim; Roche demonstrated new analyses of their drugs in patients with ILDs during the American Thoracic Society (ATS) Virtual conference

Familial Chylomicronemia Syndrome Market

Rejections and Withdrawals: Familial Chylomicronemia Syndrome Market Needs a Therapy sufficiently Effective, sufficiently Affordable

recent-pharma-news-and-update

Olema raises $54M; T3 Pharma bags $27M to advance bacterial cancer therapy program; Biofourmis and Chugai’s Collaboration; A new study on averting heart attack

Leading-Causes-of-Death-Worldwide

What are the Top Five Leading Causes of Deaths in the World?

Dilated Cardiomyopathy Market

With the Advances in Regenerative Therapy to Offer Curated Treatment Options, Off-label Therapy Market is Set to Decline for Dilated Cardiomyopathy

Precision-Medicine

Precision Medicine: An emerging approach to conventional treatment

pharma-news

Mavacamten Phase III clinical trial, FDA nod for Ovarian cancer therapy, Dyno Therapeutics & Novartis Collaboration, Abbott’s COVID-19 diagnostic kit

Telemedicine

Telemedicine: Can it be the future of healthcare?

pharma news

Ofev’s expanded use; Arkin Bio-Ventures II launch; USD 125 M for COVID-19 treatment

healthcare innovations

Top healthcare innovations changing the healthcare dynamics

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly